YF6-18874-18067
4 vaccinations
8 coded responses
40 check-ins
7 free-text entries
6 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 405 / KY
- Registered
- 2021-02-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-27
Registered in v-safe
-
2021-02-27
Dose 1 — Pfizer-BioNTech
- 2021-02-27
-
2021-02-28
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-13
-
2021-03-20
Dose 2 — Pfizer-BioNTech
- 2021-03-20
- 2021-03-21
- 2021-03-23
- 2021-03-24
- 2021-03-25
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-27
- 2021-04-03
-
2021-04-10
Survey response — day 21, dose 2MedDRA: Headache, Neuropathy peripheral, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Worsening of peripheral neuropathy. Headache.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-10
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-17
- 2021-04-24
- 2021-05-01
-
2021-06-19
Survey response — 3 months, dose 2MedDRA: Lung disorder, Sarcoidosis — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Sarcoidosis of lungsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-19
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-06-21
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2021-06-21
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2021-08-08
Dose 3 — Pfizer-BioNTech
-
2021-09-18
Survey response — 6 months, dose 2MedDRA: Chest pain, Coccydynia, Pain, Pain in jaw, Physiotherapy, Pulmonary sarcoidosis, Vitreous detachment — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Symptoms: Diagnosed with sarcoidosis of lungs. Sacroiliac joint pain. Possible neuroma affecting toes right foot. Vitreous detachment left eye. Chest pain with radiation to jaw. · Healthcare visit (other): Ancillary testing. Physical therapyMedDRA releases: 2024-11 · check-in free text available
-
2021-09-18
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-09-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2021-11-07
Survey response — 3 months, dose 3MedDRA: Chills, Dyspnoea, Fatigue, Pneumonia, Pyrexia, SARS-CoV-2 test negative — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Fever, chills, fatigue, SOB. Negative Covid test. Chest x-ray and labs diagnosed with Pneumonia.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-07
Report sent to call center — 3 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-11-09
-
2022-02-06
Survey response — 6 months, dose 3MedDRA: Ageusia, Lumbar vertebral fracture, Myalgia, Office visit, Oropharyngeal pain, SARS-CoV-2 test positive, Sacroiliac fracture, Stress fracture — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Insufficiency fracture of bilateral sacroiliac, right side fracture extending through transitional L5. Sore throat, loss of taste, fatigue and muscle pain, positive covid test per PCP office.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-06
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-08
-
2022-04-15
Dose 4 — Pfizer-BioNTech
-
2022-04-16
Survey response — days 1–6 daily, dose 4MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
- 2022-04-17
- 2022-04-18
- 2022-04-19
- 2022-04-20
- 2022-04-21
- 2022-04-22
- 2022-04-29
- 2022-05-06
- 2022-05-13
-
2022-05-21
Survey response — day 35, dose 4MedDRA: Diarrhoea, Nausea, Rib fracture — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Rib fracture, nausea and diarrheaMedDRA releases: 2024-11 · check-in free text available
-
2022-05-21
Report sent to call center — day 35, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-05-23
- 2022-05-23
- 2022-05-23
- 2022-05-23
- 2022-05-23
- 2022-05-23
- 2022-05-27
- 2022-07-15
- 2022-10-16
-
2023-04-17
Survey response — 12 months, dose 4MedDRA: Laboratory test abnormal — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-27 | Pfizer-BioNTech | |
| 2 | 2021-03-20 | Pfizer-BioNTech | |
| 3 | 2021-08-08 | Pfizer-BioNTech | No |
| 4 | 2022-04-15 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-10 | Successful 2021-06-21 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2021-06-19 | Successful 2021-06-21 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2021-09-18 | Successful 2021-09-20 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2021-11-07 | Unsuccessful | |
| 2022-02-06 | Unsuccessful | |
| 2022-05-21 | Unsuccessful |
Free text
Release 7 — day 21, dose 2
Symptoms: Worsening of peripheral neuropathy. Headache.
Release 9 — 3 months, dose 2
Symptoms: Sarcoidosis of lungs
Release 9 — 6 months, dose 2
Symptoms: Diagnosed with sarcoidosis of lungs. Sacroiliac joint pain. Possible neuroma affecting toes right foot. Vitreous detachment left eye. Chest pain with radiation to jaw.
Healthcare visit (other): Ancillary testing. Physical therapy
Release 10 — 3 months, dose 3
Symptoms: Fever, chills, fatigue, SOB. Negative Covid test. Chest x-ray and labs diagnosed with Pneumonia.
Release 11 — 6 months, dose 3
Symptoms: Insufficiency fracture of bilateral sacroiliac, right side fracture extending through transitional L5. Sore throat, loss of taste, fatigue and muscle pain, positive covid test per PCP office.
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Dizziness
Release 11 — day 35, dose 4
Symptoms: Rib fracture, nausea and diarrhea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Physiotherapy | · | · | ✓ |
| SD | Ageusia | · | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Coccydynia | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Laboratory test abnormal | · | · | ✓ |
| SD | Lumbar vertebral fracture | · | · | ✓ |
| SD | Lung disorder | ✓ | ✓ | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Neuropathy peripheral | ✓ | ✓ | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pain in jaw | · | · | ✓ |
| SD | Pneumonia | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Pulmonary sarcoidosis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rib fracture | · | · | ✓ |
| SD | Sacroiliac fracture | · | · | ✓ |
| SD | Sarcoidosis | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Stress fracture | · | · | ✓ |
| SD | Vitreous detachment | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release